Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • PPalliative care items
  • MPMedical Practitioner
  • MWMidwife
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 9357L IBANDRONATEibandronate 50 mg tablet, 28 1 28 2
MPNP 3190X IBUPROFENibuprofen 400 mg tablet, 30 3 90 3
MPMWNP 3192B IBUPROFENibuprofen 400 mg tablet, 30 1 30 0
MPNP 5368M IBUPROFENibuprofen 400 mg tablet, 30 3 90 3
MPNP 2420J IMIPRAMINEimipramine hydrochloride 10 mg tablet, 50 1 50 2
MPNP 2421K IMIPRAMINEimipramine hydrochloride 25 mg tablet, 50 1 50 2
MPNP 5137J INDACATEROLindacaterol 300 microgram powder for inhalation, 30 capsules 1 30 5
MPNP 5134F INDACATEROLindacaterol 150 microgram powder for inhalation, 30 capsules 1 30 5
MPNP 10156M INDACATEROL + GLYCOPYRRONIUMindacaterol 110 microgram + glycopyrronium 50 microgram powder for inhalation, 30 capsules 1 30 5
MPNP 2436F INDAPAMIDEindapamide hemihydrate 2.5 mg tablet, 90 1 90 1
MPNP 8532C INDAPAMIDEindapamide hemihydrate 1.5 mg modified release tablet, 90 1 90 1
MPNP 2757D INDOMETACINindometacin 100 mg suppository, 20 2 40 3
MPNP 5378C INDOMETACINindometacin 100 mg suppository, 20 2 40 3
MPNP 2454E INDOMETACINindometacin 25 mg capsule, 50 2 100 3
MPNP 5377B INDOMETACINindometacin 25 mg capsule, 50 2 100 3
MPNP 8571D INSULIN ASPARTinsulin aspart 100 units/mL injection, 1 x 10 mL vial 5 5 2
MPNP 8435Y INSULIN ASPARTinsulin aspart 100 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 8609D INSULIN ASPART + INSULIN ASPART PROTAMINEinsulin aspart 30 units/mL + insulin aspart protamine 70 units/mL injection, 5 x 3 mL syringes 5 5 1
MPNP 11426J INSULIN DEGLUDEC + INSULIN ASPARTinsulin degludec 70 units/mL + insulin aspart 30 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 11417X INSULIN DEGLUDEC + INSULIN ASPARTinsulin degludec 70 units/mL + insulin aspart 30 units/mL injection, 5 x 3 mL injection devices 5 5 1
MPNP 9040T INSULIN DETEMIRinsulin detemir 100 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 11308E INSULIN GLARGINEinsulin glargine 300 units/mL injection, 3 x 1.5 mL injection devices 5 5 1
MPNP 11302W INSULIN GLARGINEinsulin glargine 300 units/mL injection, 5 x 1.5 mL injection devices 5 5 1
MPNP 9039R INSULIN GLARGINEinsulin glargine 100 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 1921D INSULIN GLULISINEinsulin glulisine 100 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 9224L INSULIN GLULISINEinsulin glulisine 100 units/mL injection, 1 x 10 mL vial 5 5 2
MPNP 1711C INSULIN ISOPHANE BOVINEinsulin isophane bovine 100 units/mL injection, 1 x 10 mL vial 5 5 2
MPNP 1533Q INSULIN ISOPHANE HUMANinsulin isophane human 100 units/mL injection, 1 x 10 mL vial 5 5 2
MPNP 1761Q INSULIN ISOPHANE HUMANinsulin isophane human 100 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 2062M INSULIN ISOPHANE HUMAN + INSULIN NEUTRAL HUMANinsulin neutral human 50 units/mL + insulin isophane human 50 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 1426C INSULIN ISOPHANE HUMAN + INSULIN NEUTRAL HUMANinsulin neutral human 30 units/mL + insulin isophane human 70 units/mL injection, 1 x 10 mL vial 5 5 2
MPNP 1763T INSULIN ISOPHANE HUMAN + INSULIN NEUTRAL HUMANinsulin isophane human 70 units/mL + insulin neutral human 30 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 8084L INSULIN LISPROinsulin lispro 100 units/mL injection, 1 x 10 mL vial 5 5 2
MPNP 8212F INSULIN LISPROinsulin lispro 100 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 8874C INSULIN LISPRO + INSULIN LISPRO PROTAMINEinsulin lispro 50 units/mL + insulin lispro protamine 50 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 8390N INSULIN LISPRO + INSULIN LISPRO PROTAMINEinsulin lispro 25 units/mL + insulin lispro protamine 75 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 1713E INSULIN NEUTRAL BOVINEinsulin neutral bovine 100 units/mL injection, 1 x 10 mL vial 5 5 2
MPNP 1531N INSULIN NEUTRAL HUMANinsulin neutral human 100 units/mL injection, 1 x 10 mL vial 5 5 2
MPNP 1762R INSULIN NEUTRAL HUMANinsulin neutral human 100 units/mL injection, 5 x 3 mL cartridges 5 5 1
MPNP 1542E IPRATROPIUMipratropium bromide 250 microgram/mL inhalation solution, 30 x 1 mL ampoules 2 2 5
MPNP 8238N IPRATROPIUMipratropium bromide 500 microgram/mL inhalation solution, 30 x 1 mL ampoules 2 2 5
MPNP 8671J IPRATROPIUMipratropium bromide monohydrate 21 microgram/actuation pressurised inhalation, 200 actuations 2 2 5
MPNP 8247C IRBESARTANirbesartan 150 mg tablet, 30 1 30 5
MPNP 8246B IRBESARTANirbesartan 75 mg tablet, 30 1 30 5
MPNP 8248D IRBESARTANirbesartan 300 mg tablet, 30 1 30 5
MPNP 8405J IRBESARTAN + HYDROCHLOROTHIAZIDEirbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 30 1 30 5
MPNP 8404H IRBESARTAN + HYDROCHLOROTHIAZIDEirbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 30 1 30 5
MPNP 2136K IRBESARTAN + HYDROCHLOROTHIAZIDEirbesartan 300 mg + hydrochlorothiazide 25 mg tablet, 30 1 30 5
MPNP 10104T IRONiron (as ferric carboxymaltose) 500 mg/10 mL injection, 1 x 10 mL vial 2 2 1
MPNP 2593L IRON POLYMALTOSEiron (as polymaltose) 100 mg/2 mL injection, 5 x 2 mL ampoules 1 5 0
MPNP 2805P IRON POLYMALTOSEiron (as polymaltose) 100 mg/2 mL injection, 5 x 2 mL ampoules 1 5 5
MPNP 10229J IRON SUCROSEiron (as sucrose) 100 mg/5 mL injection, 5 x 5 mL ampoules 1 5 0
MPNP 8807M IRON SUCROSEiron (as sucrose) 100 mg/5 mL injection, 5 x 5 mL ampoules 1 5 5
MPNP 9436P ISOLEUCINE WITH CARBOHYDRATEisoleucine with carbohydrate containing 1 g isoleucine oral liquid: powder for, 30 x 4 g sachets 4 4 5
MPNP 9134R ISOLEUCINE WITH CARBOHYDRATEisoleucine with carbohydrate containing 50 mg isoleucine oral liquid: powder for, 30 x 4 g sachets 4 4 5
MPNP 1554T ISONIAZIDisoniazid 100 mg tablet, 100 1 100 2
MPNP 2588F ISOSORBIDE DINITRATEisosorbide dinitrate 5 mg sublingual tablet, 100 2 200 2
MPNP 1558B ISOSORBIDE MONONITRATEisosorbide mononitrate 60 mg modified release tablet, 30 1 30 5
MPNP 8273K ISOSORBIDE MONONITRATEisosorbide mononitrate 120 mg modified release tablet, 30 1 30 5
MPNP 10732W ITRACONAZOLEitraconazole 50 mg capsule, 60 1 60 5
MPNP 8196J ITRACONAZOLEitraconazole 100 mg capsule, 60 1 60 5
MPNP 10012Y IVABRADINEivabradine 5 mg tablet, 56 1 56 5
MPNP 2960T IVABRADINEivabradine 7.5 mg tablet, 56 1 56 5
MPNP 2868Y IVERMECTINivermectin 3 mg tablet, 4 2 8 2
MPNP 8359Y IVERMECTINivermectin 3 mg tablet, 4 1 4 0